 |
인쇄하기
취소
|
JW to collaborate with Samsung Medical Center
JW Pharmaceutical said Tuesday it has signed a memorandum of understanding (MOU) with Samsung Medical Center (SMC) for the research collaboration of new refractory cancer treatments.
According to the Agreement, JW Pharmaceutical will discover new cancer candidates while SMA will be responsible for screening them in patients with solid cancer, using its personalized mouse model ‘Avatar.’
‘...
According to the Agreement, JW Pharmaceutical will discover new cancer candidates while SMA will be responsible for screening them in patients with solid cancer, using its personalized mouse model ‘Avatar.’
‘...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.